Atavistik Bio Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Atavistik Bio, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing precision allosteric therapeutics for cancer. It aims to improve patient outcomes by leveraging allosteric mechanisms to achieve higher efficacy and tolerability, building an early pipeline of such agents. One program, ATV-1601, is described as a selective allosteric inhibitor for solid tumors and is expected to enter clinical testing in early 2025.

It is led by an experienced team of drug hunters with a track record of developing marketed small molecule therapies. Recent reporting indicates the company is advancing an undisclosed allosteric inhibitor targeting the JAK2 V617F mutation toward clinical proof of concept.

Sign up for free to view info

Company overview Email format